CLINICAL_TRIALS
trial_result
· 2021-10-05
Clinical Trial Update: Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects [Phase 1]
Summary
Phase 1 repeat-dose pharmacokinetics study of NRL-1 in epilepsy subjects has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurelis, Inc. | Conditions: Acute Repetitive Seizures | Phase 1 | Status: COMPLETED | Results posted: 2021-10-05